Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraindividual cross-over comparison of MultiHance and Magnevist for 3T cervico-cerebral MR angiography and perfusion in carotid artery stenosis
2006-000929-59Phase 4Completed
- Sponsor
- Bracco Group
- Start
- Nov 2006
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of gadobenate dimeglumine in carotid atheroma (CAS) (2 arms), sponsored by Bracco Group. Primary endpoint: Vascular delineation quality of supraaortic vessels in 3T contrast-enhanced MRA. Started Nov 2006; status: completed.
02
Drugs
gadobenate dimeglumine
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on 2006-000929-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000929-59.